跳至主要内容
临床试验/NCT03396900
NCT03396900已完成2 期

Periodontally Accelerated Osteogenic Orthodontics Combined With Recombinant Human Bone Morphogenetic Protein-2: An Outcome Assessment

SVS Institute of Dental Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Orthodontic treatment duration

研究概览

简要总结

rhBMP-2 has the potential to function as a regenerative material in periodontally accelerated osteogenic orthodontics (PAOO). This study aimed to assess the effects of PAOO with BMP-2 on outcomes such as treatment period, bone density, healing and pain.

详细描述

Subjects were randomly assigned into each of the following experimental groups; C+BMP: corticotomy with 0.5 μg/mL rhBMP-2 and C: corticotomy only. Clinical parameters included recording the duration of treatment period, visual analogue scale (VAS) scores and early healing index (EHI) scores. The evaluation of bone density was performed at baseline, 3 months and 6 months by using RVG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The orthodontist (HA) who performed the relevant treatment after PAOO was different from the orthodontist (MRR) randomizing the subjects into C or C+BMP groups and hence was blinded to the treatment received by the patient. One periodontist performed the PAOO surgeries (KM) and another periodontist (RVC) blinded to the therapy received by the subjects recorded the clinical and radiographic data pertinent to the study. The blind was not broken until the end of study period.

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 30 subjects with moderate crowding of lower incisors based upon Little's index and willing to undergo undergoing orthodontic treatment with extraction therapy of lower 1st premolars and PAOO were included in the study.

排除标准

  • Smokers and subjects with severe crowding of anterior teeth, periodontitis and systemic diseases were excluded from the study.

研究组 & 干预措施

RhBMP-2 Protein, Recombinant

Active Comparator

15 subjects treated with corticotomy with rhBMP-2 (C+BMP)

干预措施: RhBMP-2 Protein, Recombinant (Drug)

Conventional Corticotomy

Experimental

15 subjects treated with conventional corticotomy (C) as in the PAOO protocol

干预措施: Conventional Corticotomy (Other)

结局指标

主要结局

Orthodontic treatment duration

时间窗: Up to 6 months

Periodic recall of patients for every two weeks was done to assess the amount of crowding relieved by using digital Vernier calipers and photographs. The time taken to unravel the crowding in the pretreatment and post treatment study models and photographs was recorded.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr R Viswa Chandra

Investigator

SVS Institute of Dental Sciences

研究点 (1)

Loading locations...

相似试验

Periodontally Accelerated Osteogenic Orthodontics... | 临床试验